» Articles » PMID: 27123758

The Effects of Spacer Length and Composition on Aptamer-Mediated Cell-Specific Targeting with Nanoscale PEGylated Liposomal Doxorubicin

Overview
Journal Chembiochem
Specialty Biochemistry
Date 2016 Apr 29
PMID 27123758
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Aptamer-based targeted drug delivery systems have shown significant promise for clinical applications. Although much progress has been made in this area, it remains unclear how PEG coating would affect the selective binding of DNA aptamers and thus influence the overall targeting efficiency. To answer this question, we herein report a systematic investigation of the interactions between PEG and DNA aptamers on the surface of liposomes by using a series of nanoscale liposomal doxorubicin formulations with different DNA aptamer and PEG modifications. We investigated how the spatial size and composition of the spacer molecules affected the targeting ability of the liposome delivery system. We showed that a spacer of appropriate length was critical to overcome the shielding from surrounding PEG molecules in order to achieve the best targeting effect, regardless of the spacer composition. Our findings provide important guidelines for the design of aptamer-based targeted drug delivery systems.

Citing Articles

Effects of PEG-Linker Chain Length of Folate-Linked Liposomal Formulations on Targeting Ability and Antitumor Activity of Encapsulated Drug.

Lim C, Shin Y, Kang K, Husni P, Lee D, Lee S Int J Nanomedicine. 2023; 18:1615-1630.

PMID: 37020691 PMC: 10069508. DOI: 10.2147/IJN.S402418.


Multivalent Aptamer Approach: Designs, Strategies, and Applications.

Wang Z, Yang X, Lee N, Cao X Micromachines (Basel). 2022; 13(3).

PMID: 35334728 PMC: 8956053. DOI: 10.3390/mi13030436.


Lipoplexes to Deliver Oligonucleotides in Gram-Positive and Gram-Negative Bacteria: Towards Treatment of Blood Infections.

Pereira S, Santos R, Moreira L, Guimaraes N, Gomes M, Zhang H Pharmaceutics. 2021; 13(7).

PMID: 34210111 PMC: 8309032. DOI: 10.3390/pharmaceutics13070989.


Nucleic Acid Aptamer: A Novel Potential Diagnostic and Therapeutic Tool for Leukemia.

Tan Y, Li Y, Tang F Onco Targets Ther. 2019; 12:10597-10613.

PMID: 31824168 PMC: 6900352. DOI: 10.2147/OTT.S223946.


Functional DNA Molecules Enable Selective and Stimuli-Responsive Nanoparticles for Biomedical Applications.

Li L, Xing H, Zhang J, Lu Y Acc Chem Res. 2019; 52(9):2415-2426.

PMID: 31411853 PMC: 7103426. DOI: 10.1021/acs.accounts.9b00167.